If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Masimo (MASI).

Medtech entrepreneur Joe Kiani has been entangled in a proxy battle with activist investors and a lengthy legal dispute with ...

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

UMB Bank n.a. grew its holdings in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 180.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 191 shares of the medical equipment ...

Masimo (NASDAQ:MASI – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports.

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Telehealth and Telecare News since 2005 ...

Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her ...

(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device ...

Former President Joe Biden jetted off to California hours after President Donald Trump's inauguration. The former president ...

Masimo Taps Katie Szyman as Permanent CEO Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co. Defense and Space Company Voyager Technologies ...